| P50 | author | Yong Min Ahn | Q88683230 |
| | Won-Myong Bahk | Q90581312 |
| | Bo-Hyun Yoon | Q92227660 |
| | Young Sup Woo | Q92775882 |
| | Sang-Keun Chung | Q97524778 |
| | Kwang Heun Lee | Q116792980 |
| | Jeong-Gee Kim | Q116792996 |
| P2093 | author name string | Do-Hoon Kim | |
| | Jong Hun Lee | |
| | Ki-Chung Paik | |
| | Moon Yong Chung | |
| P2860 | cites work | A rating scale for drug-induced akathisia | Q28258433 |
| | A New Depression Scale Designed to be Sensitive to Change | Q29614720 |
| | A rating scale for mania: reliability, validity and sensitivity | Q29619299 |
| | The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor | Q33959664 |
| | Weight gain in bipolar disorder: pharmacological treatment as a contributing factor. | Q37171035 |
| | Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial | Q38376022 |
| | Maintenance of response following stabilization of mixed index episodes with olanzapine monotherapy in a randomized, double-blind, placebo-controlled study of bipolar 1 disorder | Q42605096 |
| | Relapse and impairment in bipolar disorder | Q43514252 |
| | Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors | Q44028935 |
| | A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder | Q44403599 |
| | A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania | Q44565868 |
| | Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127). | Q46086886 |
| | Reversible elevation of triglycerides in dual-diagnosis patients taking aripiprazole: a case series | Q46484489 |
| | Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126). | Q46519540 |
| | A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder. | Q47208132 |
| | Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study | Q48310435 |
| | Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. | Q52900826 |
| | Outcome in Mania. A 4-year prospective follow-up of 75 patients utilizing survival analysis | Q68610336 |
| | Course and outcome in bipolar affective disorder: a longitudinal follow-up study | Q72565096 |
| | Twelve-month outcome after a first hospitalization for affective psychosis | Q74066227 |
| P433 | issue | 8 | |
| P921 | main subject | placebo | Q269829 |
| | bipolar I disorder | Q4915474 |
| P304 | page(s) | 543-553 | |
| P577 | publication date | 2011-12-02 | |
| P1433 | published in | Human Psychopharmacology | Q15751477 |
| P1476 | title | Aripiprazole plus divalproex for recently manic or mixed patients with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind maintenance trial | |
| P478 | volume | 26 | |